Shane A. Campbell
SVP, Chief Proprietary Segment Officer
West Pharmaceutical Services Inc · WST
$2.4M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 12, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $0
- Stock Awards
- $100K
- Option Awards
- $1.2M
- Incentives
- $629K
- Other
- $481K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $0 | $100,000 | $2,402,998 |
Current Position
- Title
- SVP, Chief Proprietary Segment Officer
- Ticker
- WST · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 12, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
Accession 0001104659-26-026778.
Other West Pharmaceutical Services Executives
Eric M. Green
President and CEO, Chair of Board
West Pharmaceutical Services · WST
$7.2M
FY 2025 · DEF 14A
Robert W. McMahon
SVP, Chief Financial Officer
West Pharmaceutical Services · WST
$11.8M
FY 2025 · DEF 14A
Annette F. Favorite
SVP, Chief Human Resources Officer
West Pharmaceutical Services · WST
$1.4M
FY 2025 · DEF 14A
Kimberly B. Mac Kay
Former SVP, General Counsel and Secretary
West Pharmaceutical Services · WST
$1.3M
FY 2025 · DEF 14A
Bernard J. Birkett
Former SVP, Chief Financial Officer
West Pharmaceutical Services · WST
$2.1M
FY 2025 · DEF 14A